Literature DB >> 19106042

Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases.

Denise Josephina Johanna Hermans1, Jan Bernardus Maria Boezeman, Peter Cornelius Maria Van de Kerkhof, Paul Nicolas Maria Antonius Rieu, Carine Joanna Maria Van der Vleuten.   

Abstract

Our purpose was to get better insight into the ulceration of hemangiomas, by comparing patient characteristics of non-ulcerated hemangiomas with hemangiomas with active or past ulceration. A retrospective analysis was performed of files of patients who visited the Radboud University Medical Centre Nijmegen (UMCN), the Netherlands, between 1997 and 2007 for one or more infantile hemangiomas. The medical records of 465 patients were reviewed. Twenty three percent of the patients were diagnosed with ulceration. The size of ulcerated hemangiomas was significantly larger (28.6 cm2 vs. 6.0 cm2, p < 0.05). Predilection areas for ulceration were the head-neck region and the anogenital region. Ulceration was significantly most frequently seen in hemangiomas with a superficial (epidermal) component (98.5%, p < 0.05) and a segmental distribution (29.3%, p < 0.05). Ulceration most frequently took place during the proliferation phase of the hemangioma (83.1%). In the whole study population the male to female ratio was 1:2 compared to a tendency to more girls (1:3) for the group with ulcerated hemangiomas (p = 0.08). We conclude that larger, more superficial hemangiomas in areas more susceptible to trauma and contamination were more likely to ulcerate. This study contributes to the possibility of assessing the likelihood of ulceration in an individual patient.

Entities:  

Mesh:

Year:  2008        PMID: 19106042     DOI: 10.1684/ejd.2008.0576

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  8 in total

1.  Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.

Authors:  Preeti Tiwari; Vaibhav Pandey; Ajay N Gangopadhyay; Shiv P Sharma; Dinesh K Gupta
Journal:  Oral Maxillofac Surg       Date:  2015-10-20

2.  Negative pressure wound therapy in the treatment of ulcerated infantile haemangioma.

Authors:  Carly M Fox; Bethan Johnson; Kristen Storey; Romi Das Gupta; Roy Kimble
Journal:  Pediatr Surg Int       Date:  2015-05-13       Impact factor: 1.827

Review 3.  Treatment of infantile haemangiomas: recommendations of a European expert group.

Authors:  Peter H Hoeger; John I Harper; Eulalia Baselga; Damien Bonnet; Laurence M Boon; Marta Ciofi Degli Atti; Maya El Hachem; Arnold P Oranje; Agneta Troilius Rubin; Lisa Weibel; Christine Léauté-Labrèze
Journal:  Eur J Pediatr       Date:  2015-05-29       Impact factor: 3.183

Review 4.  Medical Management of Infantile Hemangiomas: An Update.

Authors:  Caroline Colmant; Julie Powell
Journal:  Paediatr Drugs       Date:  2021-10-22       Impact factor: 3.022

5.  Propranolol for infantile haemangiomas: experience from a tertiary center.

Authors:  Vaibhav Pandey; Preeti Tiwari; Ajay N Gangopadhyay; Dinesh K Gupta; Shiv P Sharma; Vijayendar Kumar
Journal:  J Cutan Aesthet Surg       Date:  2014-01

6.  Propranolol for treatment of infantile hemangiomas.

Authors:  Juliana Nakano de Melo; Anita Rotter; Maria Cecília Rivitti-Machado; Zilda Najjar Prado de Oliveira
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

7.  Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.

Authors:  Maya El Hachem; Francesco Gesualdo; Andrea Diociaiuti; Irene Berti; Nadia Vercellino; Valeria Boccaletti; Iria Neri; Giulio Porcedda; Antonella Greco; Claudia Carnevale; Teresa Oranges; Mario Cutrone; Pietro Dalmonte
Journal:  Ital J Pediatr       Date:  2017-04-19       Impact factor: 2.638

8.  Treatment patterns and outcomes in children with infantile hemangiomas: A retrospective observational analysis.

Authors:  Yantao Cai; Ying Ge; Carolina Oi Lam Ung; Fuli Li; Jiaqi Wang; Chenglai Xia; Hao Hu
Journal:  SAGE Open Med       Date:  2021-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.